Extensive genomic analyses have been performed on MpM tumours9–12 and for the most part, these were found to be enriched for mutations and/or other genetic alterations (e.g., splicing changes and gene deletions) that result in a decrease in tumour suppressor gene function rather than the acquisition of mutations that activate proto-oncogenes10,11. This evidence concerns the gene MTLN and neoplasm.